Advertisement

The Prevalence of Peyronie's Disease in Japan: A Study in Men Undergoing Maintenance Hemodialysis and Routine Health Checks

      ABSTRACT

      Introduction

      The incidence of Peyronie's disease (PD) in the general population is believed to be as high as 20%. However, most of the data concerning the prevalence of PD have been obtained from Caucasian populations.

      Aim

      The aim of this study was to examine the prevalence of PD in Asia and among men undergoing hemodialysis and discuss the pathophysiology of PD.

      Methods

      A total of 1,090 men who received a routine health check at our hospital (control group) as well as 130 male patients undergoing maintenance hemodialysis were enrolled. The diagnosis of PD was based on a palpable penile plaque.

      Main Outcome Measures

      Hemodialysis patients were asked about their sexual activity and completed the International Index of Erectile Function‐5 questionnaires. The differences between patients' and hemodialysis‐associated factors, comorbidities, and medications were statistically assessed for patients with and without PD.

      Results

      The prevalence of PD was significantly increased among hemodialysis patients (12 patients: 9.2%) relative the control group (six men: 0.6%) (P < 0.0001, odds ratio: 18.4). In both groups, the plaques were primarily allocated dorsally. In the hemodialysis patients with PD, the frequency of masturbation (P < 0.05) and the incidence of moderate or severe erectile dysfunction (P < 0.01) were significantly higher than those among hemodialysis patients without PD. In comparison with patients without PD, the number of acetate dialysate users was significantly higher among patients with PD (P < 0.05), and none of the PD patients used angiotensin‐related antihypertensive drugs (P < 0.05).

      Conclusions

      The prevalence of PD in healthy Japanese men is low (0.6%), which suggests the existence of racial differences in the prevalence of PD. Moreover, these results indicate that hemodialysis increases the incidence of PD. The differences in the characteristics between male hemodialysis patients with and without PD provide new insights into the pathophysiology and therapeutic window of PD. Shiraishi K, Shimabukuro T, and Matsuyama H. The prevalence of Peyronie's disease in Japan: A study in men undergoing maintenance hemodialysis and routine health checks. J Sex Med **;**:**–**.

      Keywords

      To read this article in full you will need to make a payment
      ISSM Member Login
      Login with your ISSM username and password.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mulhall J.P.
        The clinical implications of basic science research in Peyronie's disease.
        in: Levine L.A. Peyronie's disease. Humana Press, 2007: 39-57
        • Lindsay M.B.
        • Schain D.M.
        • Grambsch P.
        • Benson R.C.
        • Beard C.M.
        • Kurland L.T.
        The incidence of Peyronie's disease in Rochester, Minnesota 1950 through 1984.
        J Urol. 1991; 146: 1007-1009
        • La Pera G.
        • Pescatori E.S.
        • Calabrese M.
        • Boffini A.
        • Colombo F.
        • Andriani E.
        • Natali A.
        • Vaggi L.
        • Catuogno C.
        • Giustini M.
        • Taggi F.
        Peyronie's disease: Prevalence and association with cigarette smoking.
        Eur Urol. 2001; 40: 525-530
        • Schwarzer U.
        • Sommer F.
        • Klotz T.
        • Braun M.
        • Reifenrath B.
        • Engelmann U.
        The prevalence of Peyronie's disease: Results of a large survey.
        BJU Int. 2001; 88: 727-730
        • Rhoden E.L.
        • Teloken C.
        • Ting H.Y.
        • Lucas M.L.
        • Teodosio da Ros C.
        • Ary Vargas Souto C.
        Prevalence of Peyronie's disease in men over 50 years old in southern Brazil.
        Int J Impot Res. 2001; 13: 291-293
        • Sommer F.
        • Schwarzer U.
        • Wassmer G.
        • Bloch W.
        • Braun M.
        • Klotz T.
        • Engelmann U.
        Epidemiology of Peyronie's disease.
        Int J Impot Res. 2002; 14: 379-383
        • Mulhall J.P.
        • Creech S.D.
        • Boorjian S.A.
        • Ghaly S.
        • Kim E.D.
        • Moty A.
        • Davis R.
        • Hellstrom W.
        Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening.
        J Urol. 2004; 171: 2350-2353
        • El‐Sakka A.
        Prevalence of Peyronie's disease among patients with erectile dysfunction.
        Eur Urol. 2006; 49: 564-569
        • Arafa M.
        • Eid H.
        • El‐Badry A.
        • Ezz‐Eldine K.
        • Shamloul R.
        The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction.
        Int J Impot Res. 2007; 19: 213-217
        • Tal R.
        • Heck M.
        • Teloken P.
        • Siegrist T.
        • Nelson C.J.
        • Mulhall J.P.
        Peyronie's disease following radical prostatectomy: Incidence and predictors.
        J Sex Med. 2010; 7: 1254-1261
        • Jarow J.P.
        • Lowe F.C.
        Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunction.
        J Urol. 1997; 158: 1388-1390
        • Devine C.J.
        • Somers K.D.
        • Jordan G.H.
        • Schlossberg S.M.
        Proposal: Trauma as the cause of the Peyronie's lesion.
        J Urol. 1997; 157: 285-290
        • Moreland R.B.
        • Nehra A.
        Pathophysiology of Peyronie's disease.
        Int J Impot Res. 2002; 14: 406-410
        • Gonzalez‐Cadavid N.F.
        • Rajfer J.
        Treatment of Peyronie's disease with PDE5 inhibitors: An antifibrotic strategy.
        Nat Rev Urol. 2010; 7: 215-221
        • Ralph D.J.
        • Schwartz G.
        • Moore W.
        • Pryor J.P.
        • Ebringer A.
        • Bottazzo G.F.
        The genetic and bacteriological aspects of Peyronie's disease.
        J Urol. 1997; 157: 291-294
        • Carrieri M.P.
        • Serraino D.
        • Palmiotte F.
        • Nucci G.
        • Sasso F.
        A case‐control study on risk factors for Peyronie's disease.
        J Clin Epidemiol. 1998; 51: 511-515
        • Pryor J.
        • Akkus E.
        • Alter G.
        • Jordan G.
        • Lebret T.
        • Levine L.
        • Mulhall J.
        • Perovic S.
        • Ralph D.
        • Stackl W.
        Peyronie's disease.
        J Sex Med. 2004; 1: 110-115
        • Shiraishi K.
        • Shimabukuro T.
        • Naito K.
        Effects of hemodialysis on testicular volume and oxidative stress in human.
        J Urol. 2008; 180: 644-650
        • Rosen R.C.
        • Riley A.
        • Wagner G.
        • Osterloh I.H.
        • Kirkpatrick J.
        • Mishra A.
        The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction.
        Urology. 1997; 49: 822-830
        • Usta M.F.
        • Bivalacqua T.J.
        • Jabren G.W.
        • Myers L.
        • Sanabria J.
        • Sikka S.C.
        • Hellstrom W.J.G.
        Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease.
        J Urol. 2004; 171: 775-779
        • Casabe A.
        • Bechara A.
        • Cheliz G.
        • De Bonis W.
        • Rey H.
        Risk factors of Peyronie's disease. What does our clinical experience show?.
        J Sex Med. 2011; 8: 518-523
        • Nicolosi A.
        • Glasser D.B.
        • Kim S.C.
        • Marumo K.
        • Laumann E.O.
        Sexual behaviour and dysfunction and help‐seeking patterns in adults aged 40–80 years in the urban population of Asian countries.
        BJU Int. 2005; 95: 609-614
        • Tan H.M.
        • Marumo K.
        • Yang D.
        • Hwang T.I.
        • Ong M.L.
        Sex among Asian men and women: The global better sex survey in Asia.
        Int J Urol. 2009; 16: 507-515
        • Rosas S.E.
        • Joffe M.
        • Franklin E.
        • Strom B.L.
        • Kotzker W.
        • Brensinger C.
        • Grossman E.
        • Glasser D.
        • Feldman H.I.
        Prevalence and determinants of erectile dysfunction in hemodialysis patients.
        Kidney Int. 2001; 59: 2259-2266
        • Arslan D.
        • Aslan G.
        • Sifil A.
        • Cavdar C.
        • Celebi I.
        • Gamsari T.
        • Esen A.A.
        Sexual dysfunction in male patients on hemodialysis: Assessment with the International Index of Erectile Function (IIEF).
        Int J Impot Res. 2002; 14: 539-542
        • Cerqueira J.
        • Moraes M.
        • Glina S.
        Erectile dysfunction: Prevalence and associated variables in patients with chronic renal failure.
        Int J Impot Res. 2002; 14: 65-71
        • Turk S.
        • Guney I.
        • Altintepe L.
        • Tonbul Z.
        • Yildiz A.
        • Yeksan M.
        Quality of life in male hemodialysis patients. Role of erectile dysfunction.
        Nephron Clin Pract. 2004; 96: c21-7
        • Navaneethan S.D.
        • Vecchio M.
        • Johnson D.W.
        • Saglimbene V.
        • Graziano G.
        • Pellegrini F.
        • Lucisano G.
        • Craig J.C.
        • Ruospo M.
        • Gentile G.
        • Manfreda V.M.
        • Querques M.
        • Stroumza P.
        • Torok M.
        • Celia E.
        • Gelfman R.
        • Ferrari J.N.
        • Bednarek‐Skublewska A.
        • Dulawa J.
        • Bonifati C.
        • Hegbrant J.
        • Wollheim C.
        • Jannini E.A.
        • Strippoli G.F.
        Prevalence, correlates and predictors of sexual dysfunction in chronic kidney disease; a systematic review and meta‐analysis of observational studies.
        Am J Kidney Dis. 2010; 56: 670-685
        • Fernandes G.V.
        • dos Santos R.R.
        • de Lima L.G.
        • de Macêdo B.S.
        • da Fonte J.E.
        • de Carvalho B.S.P.
        • Coelho S.N.
        • Calado A.A.
        The impact of erectile dysfunction on the quality of life of men undergoing hemodialysis and its association with depression.
        J Sex Med. 2010; 7: 4003-4010
        • Naya Y.
        • Soh J.
        • Ochiai A.
        • Mizutani Y.
        • Ushijima S.
        • Kamoi K.
        • Ukimura O.
        • Kawauchi A.
        • Fujito A.
        • Ono T.
        • Iwamoto N.
        • Aoki T.
        • Imada N.
        • Marumo K.
        • Murai M.
        • Miki T.
        Significant decrease of the international index of erectile function in male renal failure patients treated with hemodialysis.
        Int J Impot Res. 2002; 14: 172-177
        • Kaufman J.M.
        • Hatzichristou D.C.
        • Mulhall J.P.
        • Fitch W.P.
        • Goldstein I.
        Impotence and chronic renal failure: A study of hemodynamic pathophysiology.
        J Urol. 1994; 151: 612-618
        • Palmer B.F.
        Sexual dysfunction in uremia.
        J Am Soc Nephrol. 1999; 10: 1381-1388
        • Kadioglu A.
        • Kanirali E.
        • Kendirci M.
        • Sanli O.
        • Ozsoy C.
        Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction.
        Int J Impot Res. 2004; 16: 540-543
        • Leffel M.S.
        Is there an immunogenetic basis for Peyronie's disease?.
        J Urol. 1997; 157: 295-297
        • Agrawal V.
        • Ellins E.
        • Donald A.
        • Minhas S.
        • Halcox J.
        • Ralph D.J.
        Systemic vascular endothelial dysfunction in Peyronie's disease.
        J Sex Med. 2008; 5: 2688-2693
        • Paulis G.
        • Brancato T.
        Inflammatory mechanisms and oxidative stress in Peyronie's disease: Therapeutic “rationale” and related emerging treatment strategies.
        Inflamm Allergy Drug Targets. 2012; 11: 48-57
        • Gonzalez‐Cadavid N.F.
        • Rajfer J.
        The pleiotropic effects of inducible nitric oxide synthase on the physiology and pathology of penile erection.
        Curr Pharm Des. 2005; 11: 4041-4046
        • Canguven O.
        • Lagoda G.
        • Sezen S.F.
        • Burnett A.L.
        Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats.
        J Urol. 2009; 181: 2816-2822
        • Shiraishi K.
        • Yoshida K.
        • Fujimiya T.
        • Naito K.
        Angiotensin II dependent testicular fibrosis and effects on spermatogenesis after vasectomy in the rat.
        J Urol. 2003; 170: 2104-2108
        • El‐Sakka A.I.
        • Hassoba H.M.
        • Pillarisetty R.J.
        • Dahiya R.
        • Lue T.F.
        Peyronie's disease is associated with an increase in transforming growth factor‐B protein expression.
        J Urol. 1997; 158: 1391-1394
        • Piao S.
        • Choi M.J.
        • Tumurbaatar M.
        • Kim W.J.
        • Jin H.-R.
        • Shin S.H.
        • Tuvshintur B.
        • Yin G.N.
        • Song J.S.
        • Kwon M.-H.
        • Lee S.-J.
        • Han J.-Y.
        • Kim S.-J.
        • Ryu J.-K.
        • Suh J.-K.
        Transforming growth factor (TGF)‐β type 1 receptor kinase (ALK5) inhibitor alleviates profibrotic TGF‐β1 receptor responses in fibroblasts derived from Peyronie's plaque.
        J Sex Med. 2010; 7: 3385-3395
        • Anderson J.
        • Briefel G.
        • Jones J.M.
        • Ryu J.H.
        • McGuire M.
        • Yun Y.P.
        Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2‐microglobulin plasma levels.
        Kidney Int. 1991; 40: 1110-1117
        • Paczek L.
        • Gomolka M.
        • Niemczyk S.
        • Bartlomieczyk I.
        • Gerwatowska D.
        • Sebekova K.
        • Heidland A.
        Serum growth factors in hemodialyzed patients.
        Artif Organs. 2004; 28: 314-316